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Probing the mechanism of transport and compartmentalisation
of polyamines in mammalian cells
Paul M Cullis, Ruth E Green, Louise Merson-Davies and Natalie Travis
Background: Many mammalian cells possess an active polyamine uptake
system but little is known about the molecular mechanism of this transporter.
The fate of polyamines taken up from the medium and the relationship to
polyamine homeostasis remains to be fully established. The aim of this study
was to develop a range of modified polyamines, particularly ligands
incorporating a fluorophore, to explore the structural tolerances of the
polyamine transport system and to probe the intracellular location of polyamines
acquired from the medium.
Results: We synthesised a wide range of polyamine analogues incorporating
cytotoxic agents, fluorescent chromophores and bulky substituents. All of these
analogues have been shown to be good competitive inhibitors of spermidine
uptake in a range of mammalian cells. Direct evidence for uptake of the
fluorescent polyamine analogues and their subcellular distribution was obtained
from confocal laser scanning fluorescence microscopy, which showed that they
accumulated in granular structures within the cytoplasm and not in the nucleus.
We demonstrated that their uptake is through the polyamine transport system
by showing that pretreatment with DFMO, a potent inhibitor of polyamine
biosynthesis, led to enhanced uptake, and cells deficient in the polyamine
transport system did not accumulate these polyamine analogues. 
Conclusions: The polyamine transport system has a surprisingly broad
structural tolerance. Fluorophore-containing polyamine analogues derived from
the extracellular pool are located in granular structures within the cytoplasm
and not to any great extent in the nuclei of mammalian cells. These
observations might be consistent with a mechanism involving receptor-
mediated endocytosis, and the granular ‘structures’ seen might reflect
polyamine compartmentalisation within vesicles.
Introduction
Polyamines are ubiquitous components of all cells [1] and
are required to maintain cell growth and differentiation.
The critical role of polyamines in cell proliferation has
stimulated considerable interest in polyamine metabo-
lism as a new target in chemotherapy [2,3]. Mammalian
cells possess an efficient biosynthetic pathway to the
three common polyamines, putrescine, spermidine and
spermine; polyamine levels are tightly regulated by
control of the biosynthesis and degradation of these
polyamines. In addition to the biosynthesis of
polyamines, many cells have been shown to be capable of
taking up polyamines from the extracellular medium. In
particular, a number of mammalian tumour cell lines have
been shown to contain elevated polyamine levels and
high levels of an active polyamine uptake system have
been characterised in a number of cells including rat pro-
static tumour cells [4], neuroblastoma cells [5], B16
melanoma cells [6], human colonic [7] and lung tumour
[8] cell lines, cultured human lymphocytic leukemia cells
[9], Erhlich ascites tumour cells [10], L1210 cells [11] and
ADJ/PC6 plasmacytoma cells [12]. 
Notwithstanding an incomplete understanding of the
physiological role of polyamines, their association with
proliferative responses, cell differentiation and tumour
promotion has identified polyamine regulation and
biosynthesis as an attractive target for a number of quite
different anticancer chemotherapeutic strategies
[2,3,13–15]. In this regard we [12] and others [16] have
attempted to exploit the polyamine transport systems to
deliver and target cytotoxic agents selectively to rapidly
proliferating cells (the Trojan horse approach!). The high
specific activity of the polyamine uptake systems in
tumour cells is thought to be associated with the inability
of the biosynthetic enzymes to provide the polyamine
levels needed to sustain the rapid cell division; this is
partially off-set by scavenging polyamines from the
extracellular pool [17]. It is probable that there are multi-
ple polyamine transport systems in mammalian cells with
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differing specificities and, furthermore, these systems, in
addition to transporting the natural polyamines, are
thought to be capable of transporting a significant range
of analogues, including methylglyoxal bis(guanylhydra-
zone) (MGBG) [18], paraquat [19] and N1,N12-
bis(ethyl)spermine [20]. The success of this approach
depended on two key components, the ability of the
polyamine transport system to recognise and transport
significantly modified polyamines, and the ability of
these polyamine derivatives to target DNA once inter-
nalised within the cell.
The N4-spermidine-chlorambucil conjugate 1 [21], proved
to be extremely active in in vitro experiments. It showed a
104-fold increase in cross-linking activity with naked DNA
as compared with chlorambucil [22], a 200-fold increase in
cytotoxicity in polyamine-depleted cells in culture, but a
rather smaller enhanced activity in in vivo tumour studies
[12]. The attentuation of activity in vivo could have a
number of explanations: the polyamine transport system
could fail to interact with these modified polyamines or
transport them rather inefficiently; the polyamine-drug
conjugates could be lost through competing hydrolysis
[23] or reaction with cellular components other than DNA;
the binding of 1 to DNA in cells might be weaker than to
isolated DNA; the polyamine-drug conjugate might be
prevented from reaching the nuclear DNA and so on. In
this study we provide clear evidence that a range of
polyamine analogues bind to the polyamine receptor and
are transported, which might have implications in terms of
the mechanism of the membrane translocation. In order to
address the possible intracellular binding and localisation
of modified polyamines we have exploited a number of
analogues that incorporate the fluorophore N-methyl
anthranilic acid (MANT), in conjunction with confocal
fluorescence microscopy. 
Results
Synthesis of polyamine conjugates
A series of polyamine analogues have been synthesised
that contain either the cytotoxic agent chlorambucil or the
MANT fluorophore, conjugated to the natural polyamines
spermidine and spermine or non-natural structural vari-
ants of these (Figure 1). A total of 14 polyamine analogues
are considered here that have been generated using six
polyamines, a single aminopropyl linker and four different
conjugated groups. The conjugates are named as deriva-
tives of the polyamine where the same charged state as
the parent polyamine is preserved, and the point of
attachment of the linker is signified by the prefix. The
structures of these conjugates were confirmed by 1H and
13C nuclear magnetic resonance (NMR) spectroscopy,
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Structures of the various combinations of polyamines, linker and conjugated groups that have been used in the syntheses of 14 different
polyamine probes.
high resolution mass spectrometry and the purities con-
firmed by high-performance liquid chromatography
(HPLC) analysis. Full details of the synthetic routes will
be published elsewhere.
Inhibition of spermidine uptake
The polyamine transport system in a number of cells has
been well characterised in terms of the kinetics of spermi-
dine uptake. Polyamine uptake can be easily monitored
by measuring the amount of radioactivity retained in the
cellular pellet by scintillation (Figure 2). The uptake of
spermidine in A549 cells is linear over 1–2 hours at 37°C
after which it rapidly plateaus (Figure 3a). Although
nothing is known at the molecular level about the struc-
ture of the polyamine receptor, the kinetics of uptake can
be analysed by simple Michaelis–Menten kinetics consis-
tent with a single affinity, saturatable polyamine-binding
site [12] (Figure 3b). From the data shown in Figure 3b
the spermidine transporter in A549 human lung epithelial
cells is seen to have a KM for spermidine of 0.5 µM (stan-
dard error 0.076) and a Vmax of 17 pmol/min/105 cells (stan-
dard error 0.96). From the radioactivity incorporated into
cells at saturation it is possible to estimate that the intra-
cellular concentration of spermidine accumulated from the
medium is approximately 1.9 mM. 
Binding constants for the binding of polyamine analogues
to the polyamine receptor can be determined from the
inhibition of uptake of 14C-labelled spermidine (Figure 2).
Figure 3c shows a typical set of data for the inhibition of
spermidine uptake by the N4-spermidine–MANT conju-
gate, which corresponds to a Ki for 5 of 5.9 µM. All the
polyamines and polyamine conjugates shown in Figure 1
were competitive inhibitors of spermidine uptake with Ki
values in the range 0.02–80 µM (Table 1) in A549 human
lung carcinoma epithelial cells, L1210 mouse leukemia
cells and Chinese hamster ovary (CHO) cells (Table 1). As
with simple enzyme inhibitors, the lower the Ki value the
more potent the inhibition of spermidine uptake.
Cytotoxicity studies
It is widely assumed that the cytotoxicity of nitrogen mus-
tards such as chlorambucil is associated with their ability to
cross-link DNA [24]. The polyamine conjugates that incor-
porate chlorambucil are expected, therefore, to be cyto-
toxic provided that they can gain access to cells and to
nuclear DNA. The IC50 values were determined for each
of the chlorambucil-containing compounds shown in
Figure 1 by determining the rate of incorporation of [3H]-
thymidine into cells following pretreatment with the cyto-
toxic agent (Table 2). Within this small group of
compounds it generally appears that more potent inhibitors
of polyamine uptake show greater cytotoxicity, which
would be consistent with the conjugates gaining access to
the nuclear DNA via the polyamine transport system.
It has been shown that inhibition of polyamine biosynthe-
sis leads to induction of the polyamine uptake system.
Thus, for example, pretreatment with difluoromethyl
ornithine (DFMO), a potent irreversible inhibitor of the
first step in polyamine biosynthesis, leads to a significant
increase in polyamine uptake. This effect can be used to
provide further evidence for the polyamine conjugates
being taken up by the specific polyamine transporter.
Figure 4 shows the effect of DFMO pretreatment on the
cytotoxicity of N4-spermine–chlorambucil in A549 cells.
Clearly there is a marked increase in cytotoxicity for a
number of the chlorambucil conjugates but not for chlo-
rambucil itself (Table 2). This provides strong supporting
evidence for dependence on the polyamine transporter.
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Figure 2
Schematic representation of the assay for
spermidine uptake in cells and the
measurement of competitive inhibition.
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Uptake studies by flow cytometry
The fluorescent-labelled polyamines 5, 6, 8 and 9 are rea-
sonably good surrogates for the cytotoxic polyamine conju-
gates and were designed as probes for monitoring
polyamine uptake. In a related study Aziz et al. [25]
have recently reported the synthesis and studies on the 
distribution of transported fluorescein-labeled polyamines
in cultured pulmonary artery smooth muscle cells. In order
to minimise complications from possibilities of nonspecific
hydrophobic interactions with the lipid bilayer, for
example, that could occur with a large polyaromatic fluo-
rophore we have been anxious to select a fluorophore that
is as small as possible, and hence less likely to perturb the
interactions and subsequent distribution of the polyamine
analogue. Thus using spermidine–MANT 5 the uptake of
the conjugate itself in A549 cells could be conveniently
followed by flow cytometry. The uptake kinetics showed
the expected characteristics of a receptor-mediated
process: it was saturatable, with an approximate Km of
20 µM (Figure 5a); it showed approximately linear kinet-
ics over 24 hours (Figure 5b); and the uptake was inhib-
ited by spermidine (IC50 27 µM). These characteristics are
somewhat different to those for spermidine itself in the
same cell line, for which the uptake kinetics are linear for
only 1–2 hours after which it reaches a plateau, and shows
a Km of 0.5 µM and Vmax of 17 pmol min–1 per 105 cells
(Figure 3). The plateau seen in the time course for uptake
of polyamines via the polyamine transporter signifies
feedback inhibition of the uptake through induction of
antizyme [26]. Given that uptake of spermidine–MANT 5
is linear over 24 hours it might be argued that the uptake
differs from that of the natural polyamines because this
feedback inhibition is not seen. The significantly higher
Km value for conjugate 5 compared with spermidine,
however, would be consistent with slower uptake of 5 in
this cell line such that after 24 hours the intracellular con-
centration of 5 might not have reached a sufficient level to
induce antizyme production. In support of this conclusion
are results from studies on the uptake of 5 in CHO cells
and in the related CHO–MG cells that are resistant to
MGBG by virtue of being deficient in polyamine uptake
[27]. Interestingly, the uptake of N4-spermidine–MANT
(5) in CHO cells was rapid and reached a plateau within
several hours, very similar to that seen with natural
polyamines, and indicates that accumulation of N4-sper-
midine–MANT (5) in CHO cells does show feedback
inhibition. In contrast, very slow, nonspecific uptake was
observed in CHO–MG cells under identical conditions
(Figure 6). 
We have also been able to demonstrate that the conju-
gate is intact within the cell and to estimate the intracel-
lular concentration of N4-spermidine–MANT (5) using
HPLC, both of which have implications for exploitation
in the context of drug delivery. Incubation of A549 cells
with compound 5 for 24 hours followed by washing and
extraction of the cells in acid to disrupt the membranes
led to recovery of the N4-spermidine–MANT (5) conju-
gate. The amount of 5 recovered was determined by
HPLC using UV detection and calibrated against stan-
dard solutions of N4-spermidine–MANT and MANT
alone (data not shown). Using this method it was 
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Figure 3
Kinetics of spermidine uptake in A549 cells. (a) Time course for uptake
of [14C]-spermidine. (b) Saturation kinetics for uptake of [14C]-
spermidine; average of ten independent data sets analysed by Grafit [46]
Km 0.5 µM (standard error 0.08); Vmax 17 pmol min–1 per 105 cells
(standard error 1). (c) Competitive inhibition of [14C]-spermidine uptake
by the N4-spermidine–MANT conjugate (5), Ki value of 5.9 ± 0.6 µM.
Inhibitory concentrations 2 (yellow), 5 (blue), 10 (green) and 20 (red) µM.
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possible to determine an approximate concentration of
2 × 10–15 moles per cell of spermidine–MANT, which,
assuming a mean cell volume of 3 × 10–12 l, corresponds
to an intracellular concentration of 0.7 mM. The errors
on these measurements are probably quite large but it is
clear that the intracellular concentration is at least an
order of magnitude higher than the extracellular concen-
tration, as expected for an active uptake system. The
corresponding intracellular concentration of spermidine
taken up from the medium calculated from the radioac-
tivity that is retained in the cell pellet at saturation is
1.9 mM. The fact that the concentration of spermidine
at saturation is almost three times higher than the con-
centration of N4-spermidine–MANT (5) after 24 hours
incubation would also be consistent with the suggestion
above that uptake of 5 in A549 cells is significantly
slower than for spermidine and that the concentration of
5 might not have reached a sufficient level to induce
feedback inhibition within the 24 hour incubation
period. Control experiments showed that MANT itself
does not diffuse into cells and furthermore no significant
amount of the liberated fluorophore was detected in the
cellular extracts, confirming that the conjugate is not
extensively metabolised.
Fluorescence microscopy
In addition to allowing the direct monitoring of polyamine
uptake, the fluorescently labelled polyamines offer a
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Table 1
Inhibition of uptake of spermidine in cells.
Ki values in µM*
Conjugate A549 cells L1210 cells CHO cells
Putrescine 17.2 ± 1.4
Spermine 0.02 ± 0.0006 
N1,N8-Diethyl spermidine 5 ± 1
N1,N12-Diethyl spermine 0.95 ± 0.37
N4-Spermidine–chlorambucil 1 2.8 ± 1 1.9 ± 1.3 3.0 ± 0.8
N4-Spermine–chlorambucil 2 0.4 ± 0.2 0.57 ± 0.25 0.74 ± 0.014
N3-Norspermidine–chlorambucil 3 10 ± 5 3.5 ± 0.2
N5-Homospermidine–chlorambucil 4 0.7 ± 0.3 1.07 ± 0.13
N4-Spermidine–MANT 5 5.9 ± 0.6 23.4 ± 4
N4-Spermine–MANT 6 0.4 ± 0.2
N1-Spermidine–chlorambucil 7 0.4 ± 0.2
N1-Spermine–MANT 8 0.11 ± 0.03
N1,N12-Diethyl-N4-spermine–MANT 9 7 ± 3
N1,N8-Spermidine-bis-2-nitroimidazole 10 0.6 ± 0.2
N1,N7-Norspermidine-bis-2-nitroimidazole 11 5 ± 1.6
N1,N8-Diethyl-N4-spermidine–chlorambucil 12 9.0 ± 2
*Data analysed by Grafit [46].
Table 2
In vitro cytotoxicity (IC50 µM) of polyamine conjugates in A549 cells.
Cytotoxicity Cytotoxicity after Ki
Compound IC50 (µM) DFMO pretreatment IC50 (µM) (µM)
Chlorambucil 4.2 6.1 No effect on uptake at 500 µM
N4-Spermidine–chlorambucil 1 39 0.6 2.8 ± 1
N4-Spermine–chlorambucil 2 0.1 0.03 0.4 ± 0.2
N1,N8-Diethyl-N4-spermidine–chlorambucil 12 33 35 9.0
N5-Homospermidine–chlorambucil 4 0.5 – 0.7 ± 0.3
N3-Norspermidine–chlorambucil 3 81.5 – 10 ± 1
Chlorambucil-N4-spermidine (no linker) 13 1.7 – 16.5
N1,N12-Diethyl-N4-spermine–chlorambucil 14 0.5 0.1 2.8
potentially new way to map the intracellular distribution
of polyamine analogues derived from the medium.
Figure 7 shows an image of A549 cells that have been
incubated with 5 for 24 hours taken from a conventional
fluorescence microscope. The purple fluorescent shadow
that is seen in all of these adherent cells corresponds to
the fluorescent emission from the MANT fluorophore
providing unambiguous evidence of internalisation of the
polyamine conjugate. Using conventional fluorescence
microscopy it is difficult to be confident of the internal
location of the polyamine analogue. For some individual
cells the fluorescence appears to coincide with the outline
of the nucleus, whereas for other cells it appears to be
outside the nucleus. It is clear, however, that the fluores-
cence is neither uniformly distributed within this cell, nor
tightly concentrated in the nucleus. 
Considerably greater resolution of detail is offered by con-
focal scanning laser fluorescence microscopy than by stan-
dard fluorescence microscopy, which, by virtue of the laser
excitation, allows images to be taken as ‘slices’ through the
cell. Figure 8 shows the confocal images of live A549 cells
that have incubated with 5 for 24 hours then viewed
directly on the cover slips on which they are grown. The
blue fluorescence is the emission at 436 nm corresponding
to the MANT fluorophore. The cells have been simulta-
neously stained with SYTO-13, a commercial nuclear stain
for vital cells (Molecular Probes), and this shows up in
Figure 8 as the intense green fluorescence at 488 nm
clearly showing the nuclear bodies and the margins of the
nucleus. The two fluorophores are excited separately and
the images combined, and from the individual images it is
clear that there is little of the 436 nm emission from the
nucleus suggesting that the vast majority of the N4-spermi-
dine–MANT (5) is located in the cytoplasm and not in the
nucleus. As is clearly visible in Figure 9, in which the two
individual images are displayed side-by-side in enhanced
colours, the N4-spermidine–MANT fluorescence (green)
appears to be located in granular structures that are capped
on the nucleus (stained red by the SYTO-13). These gran-
ular structures persist through cell division with the fluo-
rescent structures being shared between the daughter cells
(Figure 10). Further confirmation that the subcellular dis-
tribution of N4-spermidine–MANT (5) seen in A549 cells
was not unique to this cell line was obtained by parallel
confocal laser scanning microscopy studies on CHO cells.
Once again the fluorophore is not located in the nucleus
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Figure 4
Cytotoxicity assay based on the incorporation of [3H]-thymidine into
A549 cells following exposure to N4-spermidine–chlorambucil (1)
expressed as a percentage of control cells. The figure shows the
concentration dependence of cytotoxicity and the effects of
pretreatment of the cells with DFMO (yellow circles) which enhances
uptake via the polyamine transporter.
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Figure 5
Flow cytometric monitoring of uptake of N4-spermidine–MANT 5 in
A549 human lung epithelial cells. (a) Concentration dependence of
uptake of N4-spermidine–MANT 5 monitored by flow cytometry
showing rate saturation. (b) Time course for uptake of
N4-spermidine–MANT 5 monitored by flow cytometry.
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and appears in granular structures in the cytoplasm
(Figure 11). The corresponding images of CHO–MG cells
incubated under identical conditions showed only low
background fluorescence (data not shown). 
Discussion
The first objective of this study was to probe the structural
tolerance of the mammalian polyamine transport system.
We have shown that a considerable range of polyamine
analogues inhibit spermidine uptake. A number of earlier
studies [28–31] had explored the effects of changes in the
spacing between positive charges, conformational effects
and so on and both MGBG and paraquat appear to be
transported into cells, particularly pulmonary cells, via the
polyamine uptake system. Hitherto there have been rela-
tively few studies on uptake of significantly modified
polyamines. All of the polyamines analogues that we have
looked at to date have proved to be simple competitive
inhibitors. Despite the considerable variation in structure,
the inhibition constants vary over a range that is small
when compared with typical enzyme–substrate specificity.
From Table 1 it is clear that the number of positive
charges is a major determinant of binding to the
polyamine receptor, with spermine conjugates binding
tighter that spermidine conjugates. Norspermidine and
norspermine analogues bind more weakly than spermidine
and spermine respectively, which might reflect some pref-
erence for a particular distance between positive charges.
The N1-linked conjugates were generally more tightly
bound than the N4-linked conjugates suggesting that
there is no preference for structures with two primary
amino groups. 
The demonstration that the polyamine analogues shown
in Figure 1 are competitive inhibitors does not allow the
conclusion that they are themselves translocated across
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Figure 6
Time course for uptake of N4-spermidine–MANT (5) in Chinese
hamster ovary (CHO) cells (blue) and CHO–MG cells (red) monitored
by flow cytometry. 
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Figure 7
A549 human lung epithelial cells incubated with N4-spermidine–MANT
5 and viewed under a Ziess Axiovert 135 inverted microscope, by
phase contrast microscopy. The purple fluorescence corresponds to
the emission wavelength of the MANT fluorophore.
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Figure 8
Confocal laser scanning images of A549 cells that have been
incubated with N4-spermidine–MANT 5 for 24 h and then viewed
using a Leica TCS4D confocal laser scanning microscope, showing
accumulation of 5 in the cytoplasm. The blue fluorescence is the
emission at 436 nm corresponding to the MANT fluorophore and
the intense green fluorescence at 488 nm corresponds to emission
from SYTO-13, a commercial nuclear stain for vital cells (Molecular
Probes). The two fluorophores are excited separately and the
images combined.
the membrane. As is implied in Figure 2, a competitive
inhibitor could simply compete for the extracellular
polyamine binding site but not be transported itself.
Independent evidence must be sought to prove beyond
a doubt that these polyamine analogues are indeed
transported via the polyamine uptake system. For the
chlorambucil-containing conjugates indirect evidence
was obtained by showing that their cytotoxicity in a
range of cells in culture correlated with the binding con-
stant to the polyamine receptor, and that the cytotoxic-
ity was enhanced by pretreatment of the cells with
DFMO. The irreversible inhibition of the first step in
polyamine biosynthesis by DFMO leads to a deple-
tion of polyamine levels, which the cell attempts to
compensate for by induction of the polyamine
transport system. The fact that DFMO has no effect on
the cytotoxicity of chlorambucil but increases the cyto-
toxicity of the polyamine–chlorambucil conjugates rep-
resents convincing evidence for specific uptake by the
spermidine transporter.
The monitoring of uptake of the fluorescent polyamine
conjugates by flow cytometry provides direct evidence
that these conjugates are taken up by cells. Furthermore,
four crucial observations confirm that this is via the
polyamine transporter: firstly, the uptake is inhibited by
spermidine and spermine; secondly, the uptake is
enhance by pretreatment of the cells with DFMO
(Figure 4); thirdly, uptake of the conjugates shows satura-
tion kinetics (Figure 5a); and fourthly, uptake in CHO
cells shows feedback inhibition (Figure 6). The demon-
stration that these polyamine conjugates are rapidly taken
up by CHO cells but not by CHO–MG cells deficient in
polyamine uptake, also provides strong support for the
conclusion that all of these polyamine analogues are being
taken into cells by the spermidine transporter.
Figure 12 shows a comparison of the structures of spermi-
dine, N4-spermidine–chlorambucil (1) and N4-spermi-
dine–MANT (5) in space-filling representation. Clearly
the polyamine-conjugates are substantially more bulky
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Figure 9
Confocal laser scanning image of a single
A549 cell incubated with N4-spermidine–MANT
5 and SYTO-13 showing the emission for
(a) the MANT fluorophore at 436 nm (green)
and (b) the superimposition of emission at
436 nm, the MANT fluorophore, and 488 nm,
the SYTO-13 fluorophore (red; right image). 
Figure 10
Confocal laser scanning image of an A549
cell that has been incubated with SYTO-13
and N4-spermidine–MANT 5 undergoing
division, showing (a) the superimposed
emissions for the MANT fluorophore at
436 nm (green) and the SYTO-13 fluorophore
at 488 nm (red), and (b) emission for the
MANT fluorophore alone showing the
distribution of the granular structures between
the two daughter cells. 
than spermidine itself, and yet, as demonstrated above,
they are still recognised and transported by the spermi-
dine uptake system. 
The second aspect of this study has been the related
issues of the mechanism of polyamine uptake and intra-
cellular localisation of the polyamines once internalised
within the cell. There has been a considerable amount of
effort put into localising the endogenous polyamines sper-
midine and spermine as part of the general attempt to
delineate the precise physiological role of these ubiqui-
tous molecules [32]. Cytochemical [33], immunological
and subcellular fractionation methods [34,35] have all
been developed and applied to a number of different
tissue types but these have reached contradictory conclu-
sions depending on the method of analysis. Subcellular
fractionation of HeLa cells and chicken erythrocytes in oil
(to minimise polyamine redistribution) demonstrated that
spermidine and spermine are concentrated in the nuclei
and chromosomes [33], which is in agreement with histo-
chemical staining [36]. Cells containing uncondensed
nuclei such as rat liver cells, however, stain for polyamines
predominantly in the cytoplasm but on subcellular frac-
tionation in organic solvents the nuclear polyamine levels
appear to be equal or higher [34]. Unfortunately none of
these methods is capable of studying viable cells and all
are to a greater or lesser extent prone to either possible
redistribution of polyamines during manipulations of the
cells or inaccessibility of particular polyamine pools with
respect to staining. In this present study we have looked
directly at viable cells and no disruption of the cellular
integrity was involved. On the basis of these results it is
clear that the modified polyamines obtained from the
extracellular pool are not located to any significant extent
in the nuclei of these A549 human lung carcinoma cells
(Figures 7–9) or CHO cells (Figure 11). The fluorescence
intensity is seen in the cytoplasm of these cells rather than
the nuclei and the images from confocal scanning laser
microscopy clearly show that this fluorescence is not
evenly distributed but is associated with granular struc-
tures. This distribution persists through many cell divi-
sions suggesting that the polyamine pools that we are
observing are not exchanging during the cell cycle. Inter-
estingly we have noted that the polyamine-containing
granular structures even appear to be shared between the
two daughter cells on division (Figure 10). These results
are very similar to those reported by Aziz et al. [25] using
their fluorescein-spermidine conjugate in pulmonary
artery smooth muscle cells which, taken together with this
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Figure 11
Confocal laser scanning image of CHO cells after incubation with
N4-spermidine–MANT (5) showing the polyamine conjugate located
in granular structures in the cytoplasm in a similar pattern to that seen
in A549 cells.
Figure 12
Space-filling models of (a) spermidine; (b) N4-spermidine–-
chlorambucil (1); and (c) N4-spermidine–MANT (5).
present study, demonstrates that this distribution of
exogenously derived polyamines is seen in a diverse range
of mammalian cells types.
The nature of these granular structures is unclear but on
the basis of size and shape they would be consistent with
vesicles. In an attempt to determine whether the
polyamine 5 is initially transported into the free cytoplasm
and subsequently the fluorescence becomes more readily
visualised upon compartmentalisation within these vesi-
cles we can compare the results from flow cytometry with
the appearance under the confocal fluoresecence micro-
scope. It is clear that the rate of uptake determined by
flow cytometry closely matches the profile of appearance
of the fluorophore within the vesicles. This would only be
the case if transport and compartmentalisation were
coupled or if transport across the membrane was slow but
subsequent internal compartmentalisation was fast. 
If these polyamines are indeed sequestered in vesicles
this presents at least two paradoxes. Firstly, it is generally
accepted that the N4-spermidine–chlorambucil conjugate
1 owes its cytotoxicity to its ability to cross-link DNA and
yet the bulk of the material would appear not to have
access to the nucleus. Secondly, the feedback inhibition of
polyamine uptake involves interaction of the exogenous
polyamine with ribosomes to induce antizyme production.
Clearly, in CHO cells the majority of the polyamine ana-
logue is still associated with these granular structures and
yet feedback inhibition is still observed. From the confo-
cal laser scanning fluorescence microscopy, however, it
would be impossible to exclude the possibility that
although the majority of the polyamine analogue is
sequestered ~10% might be released from these vesicles,
which, in the case of conjugate 1, would almost certainly
be sufficient to be cytotoxic. Indeed, it can be seen from
Figure 11 that there does appear to be a more uniform
diffuse background blue fluorescence that could be ‘free’
polyamine–MANT conjugate.
Transport of specific molecules across the membrane is
essential in all cells not only in terms of nutrient uptake
and waste excretion but also to fulfil a multitude of regula-
tory and other functions [37]. Membrane transport is prob-
ably best characterised in prokaryotic systems and its
importance is illustrated by the fact that in E. coli almost
20% of the genes so far identified appear to be associated
with transport functions. In comparison only a limited
number of mammalian transporters have been charac-
terised, but efficient endocytosis in such cells might
obviate the need for some of the highly specific protein
transporters that are seen in prokaryotes [37]. 
Despite the considerable literature on active uptake of
polyamines into cells, including expression of the
polyamine receptor into CHO cells [38], little is known
about the mechanism of transfer of polyamines across the
cell membrane in eukaryotes. In terms of the polyamine
transport processes observed in this study there are pre-
sumably two extreme mechanisms of uptake, either a spe-
cific protein transporter with characteristics of a
membrane ‘channel’ or a receptor-mediated endocytosis
(Figure 13). Fluid-phase endocytosis can be ruled out
because the fluorescent conjugate 5 is accumulated intra-
cellularly above the external concentration and the uptake
is inhibited by a competing polyamine. Whatever mecha-
nism is proposed it must be consistent with the following
key observations: first, the extracellularly derived
polyamine analogues are located in structures consistent
with vesicles or secondary endosomes; second, 5 appears
to co-localise with Lucifer yellow, a dye used as a marker
for endosomes [39]; third, the mechanism of influx is tol-
erant of significant modification of the polyamine without
major perturbation of uptake; fourth, the greater the posi-
tive charge the tighter the binding to the polyamine trans-
porter; and fifth, the observed distribution of the
fluorophore does not significantly change over 24 hours.
As is implicit in the cartoons shown in Figure 13, we have
assumed that the protein ‘channel’ will show a stricter
structural requirement than receptor-mediated endocyto-
sis (see below). In the case of endocytosis, if the inter-
action of the receptor is principally with the ‘head’ of the
polyamine conjugate, extensive variations in the ‘tail’
726 Chemistry & Biology 1999, Vol 6 No 10
Figure 13
Schematic representation of two alternative transport mechanisms:
(a) transmembrane channel; (b) receptor-mediated endocytosis.
Protein ‘channel’
Cytoplasm
Endosome
Receptor-mediated
endocytosis
Cytoplasm
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(a) (b)
might well be tolerated without impeding the endocytosis
step. There are examples of eukaryotic carrier-mediated
transporters with apparently broad substrate tolerance,
notably the multidrug resistance transporter [40–43]. In
this latter case the substrates all tend to be lipophilic,
which makes the task of translocation across the
hydrophobic lipid bilayer inherently easier, and this might
mean that it is sufficient to have a large, flexible
hydrophobic binding pocket. In the case of translocation
of more polar ligands, if a protein is to chaperone the
ligand across the membrane (a ‘flip-flop’ mechanism) it
will be necessary to ‘mask’ these polar groups (i.e. develop
precise binding interactions) in order to overcome the
high energetic cost of removing these polycations from the
aqueous environment. A mechanism involving creation of
an aqueous channel would get around this but would be
expected to allow passage of the polyamine conjugates
into the cytoplasm. 
Finally, it is necessary to address the question of whether
or not the observations and conclusions made concerning
the uptake and localisation of polyamine–MANT deriva-
tives can be extrapolated to the natural polyamines them-
selves. It is clear that the fundamental properties associated
with the transporting of these polyamine conjugates are
remarkably similar to those for the polyamines themselves:
firstly, Km and Vmax values for natural polyamines and
polyamine conjugates are in tolerable agreement; secondly,
the same enhancement of uptake by pretreatment with
DFMO is seen for natural polyamines and a wide range of
polyamine conjugates; thirdly, feedback inhibition of
uptake of 5 in CHO cells is similar to that seen for spermi-
dine; fourthly, direct competitive inhibition between sper-
midine and these polyamine analogues for uptake is
observed; and fifthly, intracellular concentration of exoge-
nous polyamines and polyamine conjugates at saturation
are closely similar. If natural polyamines are playing a
crucial role(s) in terms of regulation of cell growth and dif-
ferentiation it will be necessary to tightly regulate the con-
centrations of ‘free’ polyamines. One way of doing this
would be to sequester polyamine in vesicles from where
they can be released in response to some appropriate cell
signal. It would be extremely interesting if these granular
structures are indeed polyamine pools, but such a conclu-
sion would be premature at this stage. It is equally possible
that the polyamine conjugates are processed by the cell in
an entirely different manner to the natural polyamine.
Clearly the mammalian polyamine transport pathways are
complex and as yet poorly characterised at the molecular
level. This present study has led, however, to a number of
key observations concerning the uptake and localisation of
extracellularly derived polyamine analogues against which
mechanistic proposals can be tested. Influx and efflux of
polyamines might have a significant physiological role, as yet
to be defined, and it has been suggested that endogenous
and exogenously derived polyamines might exist in essen-
tially nonexchangeable pools [1,44]. Our results provide
some support for these suggestions. Finally, the probes
described in this manuscript have many potential applica-
tions in looking at polyamine uptake generally and at
changes that might occur to the polyamine compartmentali-
sation during the cell cycle or in response to external agents.
Significance
Polyamines play a crucial role in regulation of cell growth
and differentiation. Mammalian cells satisfy this require-
ment via the de novo biosynthesis of polyamines and/or
the exploitation of an efficient polyamine uptake mecha-
nism that can acquire polyamines from the extracellular
milieu. Despite a lack of full understanding of the role that
polyamines play in controlling cell division, there has been
considerable interest in polyamine regulation as a new
target for chemotherapy. One approach has been to
attempt to exploit the high specific activity of the
polyamine transport system that is widely seen in tumour
cells to deliver selectively cytotoxic agents. This present
study has demonstrated a broad tolerance of the
polyamine transporter of three mammalian cells (A549
human lung epithelial carcinoma cells, CHO cells and
L1210 human lymphocytic leukemia cells) towards a
wide range of polyamine conjugates. Fluorescently
labelled polyamines have been developed to probe the
uptake and intracellular distribution of polyamines using
confocal laser scanning fluorescence microscopy. These
studies have shown that exogenously derived polyamine
analogues are localised in the cytoplasm of cells, in granu-
lar structures that resemble endosomes, and are not found
to any significant extent in the nucleus. The mechanism
of polyamine uptake in mammalian cells is poorly under-
stood at the molecular level and these present observa-
tions might have important implications in advancing this
understanding. These results also suggest that there is
considerable potential for exploiting the polyamine trans-
port system in the delivery of cytotoxic agents. Finally,
this study has provided molecular probes that might prove
useful in unravelling the role of polyamines in controlling
cell proliferation and differentiation.
Materials and methods
Cell lines and bacterial strains
A549, human epithelial lung carcinoma cells were used throughout this
study and were a gift from Dr. C. Courage, CMHT, Leicester University.
Cells were seeded at 5–10 × 104 cells/ml and maintained in Nutrient
Mix; F-12 (Hams) with Glutamax (Gibco BRL, cat 31765-027) supple-
mented with foetal calf serum (PAA Laboratories Ltd, UK), penicillin
(100 iu/ml) and streptomycin (100 µg/ml).
CHO cells and CHO–MG cells were a gift from Prof. A.E. Pegg, Penn-
sylvania State University College of Medicine, Hershey, USA. Cells
were maintained in MEM Alpha medium (Gibco BRL, cat 32561-021)
supplemented with foetal calf serum (PAA Laboratories Ltd, UK), peni-
cillin (100 iu/ml) and streptomycin (100 µg/ml). All cell lines tested
negative for mycoplasm contamination.
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Once cells approached confluence, spermidine–MANT (50 µM) was
added to the media and the cells were incubated for a further 24 h.
Cells were washed once in 0.9% sodium chloride containing 1 mM
spermidine, then twice with phosphate buffered saline (PBS) and
either viewed directly or collected for extraction of internal
polyamines. In co-staining experiments using SYTO-13 (Molecular
Probes), the DNA stain was added 1 h before the end of incubation
with spermidine–MANT.
Determination of polyamine uptake
To study the uptake of [14C]-spermidine A549 cells were seeded into
24- well tissue culture plates (Nunc –1 × 105 cells/well) and incubated
for 16 h to form a monolayer. Cells were incubated with either [14C]-
radiolabelled spermidine (112 µCi/mmol, Amersham International) at
various concentrations over periods up to 4 h. After incubation, the
plates were placed on ice and the cells were washed with cold 0.9%
NaCl plus 1 mM spermidine, to displace any radiolabelled spermidine
still attached to the cell surface. Cells were disrupted by the addition of
1 M NaOH (400 µl) and incubation at 60ºC for 30 min–1 h. Samples
were neutralised by the addition of an equal volume of 1 M HCl. Dupli-
cate samples (400 µl) were added to 4 ml Optiphase ‘Safe’ and
radioactivity determined in a Wallac scintillation counter. The results
were expressed as pmol spermidine uptake/min/105 cells.
Cytotoxicity assay
A549 human epithelial lung carcinoma cells were seeded in 24-well
plates at 500 µl of 1 × 104 cells/ml and cultured for 24 h. Polyamine
conjugates were added to give the appropriate concentration in a final
volume of 1 ml. Cells were cultured for a further 72 h. [3H]-Thymidine
(0.25 µCi) was added and the cells cultured for a further 2 h. The cells
were washed twice with cold 0.9% NaCl solution containing 1 mM
thymidine. To each well was added 1 ml cold trifluoroacetic acid solu-
tion (10%) and the wells left for 10 min. The resulting precipitate was
dissolved in 400 µl NaOH solution (1 M), and neutralised with HCl
solution (1 M) then the tritium content determined by scintillation
counting. The [3H]-thymidine incorporation is expressed as a percent-
age of the incorporation seen in the control wells (no polyamine-conju-
gate added). Each data point is the average of experiments carried out
in triplicate.
Microscopy
Cells were viewed under a Ziess Axiovert 135 inverted microscope by
phase contrast microscopy. A UVG 365 UV filter (Ziess) was used to
observe the fluorescence of compounds with the MANT group and a
Blue 450–490 filter (Ziess) was used to observe SYTO-13. Confocal
images were obtained using a Leica TCS4D confocal laser scanning
microscope, excitation was via a laser in the UV region
(spermidine–MANT), or at 488 nm (SYTO-13).
Determination of intracellular polyamines
Cells (5–10 × 106) were scraped into 2 ml PBS and pelleted. The cell
pellet was then resuspended in 0.2 M perchloric acid (200 µl) and
incubated for 2 h at 4°C. The precipitate was removed by centrifuga-
tion and the supernatant neutralised by the addition of saturated
sodium carbonate (10 µl) and saturated sodium hydrogen carbonate
(120 µl). This method was modified from Chen et al. [45].
The extract was then separated by HPLC using a reverse-phase column
(C18, 5 µ, BDS column, Hypersil) connected to a Gilson 715 system. A
Dynamax absorbance detector (model UV-1, Rainin) was used to detect
the spermidine–MANT compounds. The solvent system used was
eluent A; 0.1 M ammonium acetate pH 6, eluent B; acetonitrile, gradient
0 min (20% B); 20 min (60% B); 23 min (80% B); 26 min (80% B);
28 min (20% B); 30 min (20% B); flow rate was 1 ml/min at room tem-
perature. The elution was monitored and quantitated by UV at 340 nm.
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